{"id":624961,"title":"Health Product InfoWatch: October 2022 - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T07:17:00.377000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/october-2022.html","snippet":"Health Product InfoWatch: October 2022 Contents Health products mentioned in this issue Coronavirus disease (COVID-19) Drug and vaccine authorizations and communications for COVID-19 Actemra (tocilizumab) Comirnaty Original & Omicron BA.4/BA.5 Bivalent Vaccine (COVID-19 mRNA…","rawSnapshotUrl":"/api/snapshots/raw/624961","browseUrl":"https://replay.healtharchive.ca/job-6/20260227071700/https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/october-2022.html#ha_snapshot=624961","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}